Cargando…
Author Correction: The number of osteoclasts in a biopsy specimen can predict the efficacy of neoadjuvant chemotherapy for primary osteosarcoma
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8055875/ https://www.ncbi.nlm.nih.gov/pubmed/33875768 http://dx.doi.org/10.1038/s41598-021-88629-2 |
_version_ | 1783680531056033792 |
---|---|
author | Araki, Yoshihiro Yamamoto, Norio Hayashi, Katsuhiro Takeuchi, Akihiko Miwa, Shinji Igarashi, Kentaro Higuchi, Takashi Abe, Kensaku Taniguchi, Yuta Yonezawa, Hirotaka Morinaga, Sei Asano, Yohei Ikeda, Hiroko Nojima, Takayuki Tsuchiya, Hiroyuki |
author_facet | Araki, Yoshihiro Yamamoto, Norio Hayashi, Katsuhiro Takeuchi, Akihiko Miwa, Shinji Igarashi, Kentaro Higuchi, Takashi Abe, Kensaku Taniguchi, Yuta Yonezawa, Hirotaka Morinaga, Sei Asano, Yohei Ikeda, Hiroko Nojima, Takayuki Tsuchiya, Hiroyuki |
author_sort | Araki, Yoshihiro |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8055875 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-80558752021-04-22 Author Correction: The number of osteoclasts in a biopsy specimen can predict the efficacy of neoadjuvant chemotherapy for primary osteosarcoma Araki, Yoshihiro Yamamoto, Norio Hayashi, Katsuhiro Takeuchi, Akihiko Miwa, Shinji Igarashi, Kentaro Higuchi, Takashi Abe, Kensaku Taniguchi, Yuta Yonezawa, Hirotaka Morinaga, Sei Asano, Yohei Ikeda, Hiroko Nojima, Takayuki Tsuchiya, Hiroyuki Sci Rep Author Correction Nature Publishing Group UK 2021-04-19 /pmc/articles/PMC8055875/ /pubmed/33875768 http://dx.doi.org/10.1038/s41598-021-88629-2 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Author Correction Araki, Yoshihiro Yamamoto, Norio Hayashi, Katsuhiro Takeuchi, Akihiko Miwa, Shinji Igarashi, Kentaro Higuchi, Takashi Abe, Kensaku Taniguchi, Yuta Yonezawa, Hirotaka Morinaga, Sei Asano, Yohei Ikeda, Hiroko Nojima, Takayuki Tsuchiya, Hiroyuki Author Correction: The number of osteoclasts in a biopsy specimen can predict the efficacy of neoadjuvant chemotherapy for primary osteosarcoma |
title | Author Correction: The number of osteoclasts in a biopsy specimen can predict the efficacy of neoadjuvant chemotherapy for primary osteosarcoma |
title_full | Author Correction: The number of osteoclasts in a biopsy specimen can predict the efficacy of neoadjuvant chemotherapy for primary osteosarcoma |
title_fullStr | Author Correction: The number of osteoclasts in a biopsy specimen can predict the efficacy of neoadjuvant chemotherapy for primary osteosarcoma |
title_full_unstemmed | Author Correction: The number of osteoclasts in a biopsy specimen can predict the efficacy of neoadjuvant chemotherapy for primary osteosarcoma |
title_short | Author Correction: The number of osteoclasts in a biopsy specimen can predict the efficacy of neoadjuvant chemotherapy for primary osteosarcoma |
title_sort | author correction: the number of osteoclasts in a biopsy specimen can predict the efficacy of neoadjuvant chemotherapy for primary osteosarcoma |
topic | Author Correction |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8055875/ https://www.ncbi.nlm.nih.gov/pubmed/33875768 http://dx.doi.org/10.1038/s41598-021-88629-2 |
work_keys_str_mv | AT arakiyoshihiro authorcorrectionthenumberofosteoclastsinabiopsyspecimencanpredicttheefficacyofneoadjuvantchemotherapyforprimaryosteosarcoma AT yamamotonorio authorcorrectionthenumberofosteoclastsinabiopsyspecimencanpredicttheefficacyofneoadjuvantchemotherapyforprimaryosteosarcoma AT hayashikatsuhiro authorcorrectionthenumberofosteoclastsinabiopsyspecimencanpredicttheefficacyofneoadjuvantchemotherapyforprimaryosteosarcoma AT takeuchiakihiko authorcorrectionthenumberofosteoclastsinabiopsyspecimencanpredicttheefficacyofneoadjuvantchemotherapyforprimaryosteosarcoma AT miwashinji authorcorrectionthenumberofosteoclastsinabiopsyspecimencanpredicttheefficacyofneoadjuvantchemotherapyforprimaryosteosarcoma AT igarashikentaro authorcorrectionthenumberofosteoclastsinabiopsyspecimencanpredicttheefficacyofneoadjuvantchemotherapyforprimaryosteosarcoma AT higuchitakashi authorcorrectionthenumberofosteoclastsinabiopsyspecimencanpredicttheefficacyofneoadjuvantchemotherapyforprimaryosteosarcoma AT abekensaku authorcorrectionthenumberofosteoclastsinabiopsyspecimencanpredicttheefficacyofneoadjuvantchemotherapyforprimaryosteosarcoma AT taniguchiyuta authorcorrectionthenumberofosteoclastsinabiopsyspecimencanpredicttheefficacyofneoadjuvantchemotherapyforprimaryosteosarcoma AT yonezawahirotaka authorcorrectionthenumberofosteoclastsinabiopsyspecimencanpredicttheefficacyofneoadjuvantchemotherapyforprimaryosteosarcoma AT morinagasei authorcorrectionthenumberofosteoclastsinabiopsyspecimencanpredicttheefficacyofneoadjuvantchemotherapyforprimaryosteosarcoma AT asanoyohei authorcorrectionthenumberofosteoclastsinabiopsyspecimencanpredicttheefficacyofneoadjuvantchemotherapyforprimaryosteosarcoma AT ikedahiroko authorcorrectionthenumberofosteoclastsinabiopsyspecimencanpredicttheefficacyofneoadjuvantchemotherapyforprimaryosteosarcoma AT nojimatakayuki authorcorrectionthenumberofosteoclastsinabiopsyspecimencanpredicttheefficacyofneoadjuvantchemotherapyforprimaryosteosarcoma AT tsuchiyahiroyuki authorcorrectionthenumberofosteoclastsinabiopsyspecimencanpredicttheefficacyofneoadjuvantchemotherapyforprimaryosteosarcoma |